Skip to main content
Logo GMV

Main navigation

  • Sectors
    • Icono espacio
      Space
    • Icono Aeronáutica
      Aeronautics
    • Icono Defensa y Seguridad
      Defense and Security
    • Icono Sistemas Inteligentes de Transporte
      Intelligent Transportation Systems
    • Icono Automoción
      Automotive
    • Icono Ciberseguridad
      Cybersecurity
    • Icono Servicios públicos Digitales
      Digital Public Services
    • Icono Sanidad
      Healthcare
    • Icono Industria
      Industry
    • Icono Financiero
      Financial
    • Icono Industria
      Services
    • All Sectors

    Highlight

    European Conference on Space Debris
    Our present and future: A tour through the European Conference on Space Debris
  • Talent
  • About GMV
    • Get to Know the Company
    • History
    • Management Team
    • Certifications
    • Corporate Social Responsibility
  • Communication
    • News
    • Events
    • Blog
    • Magazine GMV News
    • Press Room
    • Media library
    • Latest from GMV

Secondary navigation

  • Products A-Z
  • GMV Global
    • Global (en)
    • Spain and LATAM (es - ca - en)
    • Germany (de - en)
    • Portugal (pt - en)
    • Poland (pl - en)
    • All branches and all GMV sites
  • Home
  • Communication
  • News
Back
New search
Date
  • Healthcare

GMV obtains authorization for selling its intraoperative radiation therapy planning system in the USA

17/01/2012
  • Print
Share

GMV has received official authorization from the USA’s Food and Drug Administration (FDA) to market its intraoperative radiation therapy planning system, radiance™, in the USA.

The system, a worldwide trailblazer, was developed by GMV in collaboration with the research team of the Oncology Department and the Experimental Surgery and Medicine Department of the Hospital General Universitario Gregorio Marañón, together with a set of prestigious Spanish hospitals and universities.

This revolutionary new system enables all the decisions of a surgical operation and the radiation effects on the patient to be pre-planned before the patient actually receives any radiation dose.

It is a sure and reliable method that boosts irradiation efficiency and precision in any operation, benefiting not only the patients themselves, cutting down the operation time and increasing their quality of life, but also the surgeons and oncologists, who can enter the operating theater with many of the decisions previously assessed and agreed.

The technological complexity of this and other GMV developments calls for different quality standards in its processes. For this reason radiance™ had already obtained CE Mark approval authorizing its marketing in all EU member states and has now added this authorization from the USA’s Food and Drug Administration. This means that GMV can continue its worldwide promotion and expansion process in two of today’s most important IORT markets. 

  • Print
Share

Related

Premios IA con Impacto Social
  • Healthcare
The GMV-led Tartaglia project wins the "AI with Social Impact Prize".
np_011_ia-lung-scan.jpg
  • Healthcare
Innovative artificial intelligence-based simulator for the diagnosis of interstitial lung diseases
np_011_ia-lung-scan.jpg
  • Healthcare
GMV designs a groundbreaking artificial intelligence-based simulator for diagnosing interstitial lung diseases

Contact

Europaplatz 2
64293 Darmstadt | Deutschland
Tel. +49 6151 3972 970
Fax. +49 6151 8609 415

Zeppelinstraße, 16
82205 Gilching | Deutschland
Tel. +49 (0) 8105 77670 150
Fax. +49 (0) 8105 77670 298

Contact menu

  • Contact
  • GMV around the world

Blog

  • Blog

Sectors

Sectors menu

  • Space
  • Aeronautics
  • Defense and Security
  • Intelligent Transportation Systems
  • Automotive
  • Cybersecurity
  • Digital Public Services
  • Healthcare
  • Industry
  • Financial
  • Services
  • Talent
  • About GMV
  • Shortcut to
    • Press Room
    • News
    • Events
    • Blog
    • Products A-Z
© 2025, GMV Innovating Solutions S.L.

Footer menu

  • Contact
  • Legal Notice
  • Privacy Policy
  • Cookie Policy
  • Impressum

Footer Info

  • Commitment to the Environment
  • Financial Information